[3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum

British Journal of Pharmacology

Volumn 126, Issue 1, 1999, Pages 179-188

  Hemedah, Maggie ^a   Coupar, Ian M ^a   Mitchelson, Fred J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

5 ht7 receptor; Guinea pig ileum; Rat brain; Rat jejunum; 3h mesulergine

Indexed keywords

5 CARBAMOYLTRYPTAMINE; 5 METHOXYTRYPTAMINE; 5-CARBOXAMIDOTRYPTAMINE; 8 [4 (5 AMINO 2,4 DIMETHOXYBENZOYL)BUTYL] 1,3,8 TRIAZASPIRO[4.5]DECANE 2,4 DIONE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; ERGOLINE DERIVATIVE; MESULERGINE; ONDANSETRON; SCAVENGER; SEROTONIN; SEROTONIN 2C RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SPIRO COMPOUND; SULFONAMIDE; SUMATRIPTAN; TRITIUM; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; CINANSERIN; METERGOLINE; PINDOLOL; RISPERIDONE; RITANSERIN; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL; ARTICLE; BINDING COMPETITION; BINDING SITE; BRAIN; DOSE RESPONSE; DRUG EFFECT; FEMALE; GUINEA PIG; ILEUM; IN VITRO STUDY; JEJUNUM; MALE; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; RADIOASSAY; RAT; WISTAR RAT; ANIMAL TISSUE; CONTROLLED STUDY; DRUG POTENCY; INTESTINE CONTRACTION; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING;

5-METHOXYTRYPTAMINE; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOLINES; FEMALE; FREE RADICAL SCAVENGERS; GUINEA PIGS; ILEUM; JEJUNUM; MALE; MUSCLE CONTRACTION; ONDANSETRON; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SPIRO COMPOUNDS; SULFONAMIDES; SUMATRIPTAN; TRITIUM;

EID: 0032589137     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702293     Document Type: Article

References (49)

1. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Phannacol. Chcmother., 14, 48-58.
2. 2+ calmodulinsensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptaminc subtype 5-HT7A receptor. J. Biol. Cliem., 273, 1746917476.
3. BARD, J.A., ZGOMBICK, J., ADHAM, N., VAYSSE, P., BRANCHEK, T.A. & WEINSHANK, R.L. (1993). Cloning of a novel serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Client. ,31, 23422-23426.
4. BOESS, F.G. & MARTIN, I.L. (1994). Review: molecular biology of 5HT receptors. NeuropliarmacoL, 33, 275-317.
5. BONHAUS, D.W., WEINHARDT, K.K., TAYLOR, M., DESOUZA, A., MCNEELEY, P.M., SZCZEPANSKI, K., FONTANA, D.J., TR1NH, J., ROCHA, C.L., DAWSON, M.W., FLIPPIN, L.A. & EGLEN, R.M. (1997). RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacol., 36, 621-629.
6. BRADFORD, M.M. (1976). A rapid sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
7. CARTER, D., CHAMPNEY, M., HWANG, B. & EGLEN, R.M. (1995). Characterization of post-junctional 5-hydroxytryptamine (5-HT) receptor mediating relaxation of guinea-pig isolated ileum. Ear. J. Phannacol, 28, 243-250.
8. CASTRO, E.M., ROMoN, T., CASTILLO, M.J., DEL OLMO, E., PAZOS, A. & DE ARCO, C. (1997). Identification and characterisation of a new serotonergic recognition site with high affinity for 5carboxamidotryptamine in mammalian brain. J. NeuropharmaroJ., 69, 2123-2131.
9. CHENG, Y.C. & PRUSOFF, W.H. (1973). Relationship between the inhibitor constant (Kj) and the concentration of inhibitor which causes 50% inhibition (ICso) of an enzymatic reaction. Biochem. Phannacol., 22, 30-3108.
10. GLOSSE, A. (1983). [3H]-MesuIergine, a selective ligand for serotonin-2 receptors. Life Sei., 32, 2485-2495.
11. CUSHING, D.J. & COHEN, M.L. (1992). Sertonin-induced relaxation in canine coronary artery smooth muscle. J. Phannacol. Exp. Ther.,263, 12-129.
12. DYER, S.M., BEXIS, S., MANE, M.T., DE LA LANDE, I.S., FREWIN, D.B. & HEAD, R.J. (1994). Interactions between 5-hydroxytryptamine, noradrenaline and the thromboxane-A(2) mimetic U44069 in the marmoset isolated aorta. Clin. Exp. Phannacol. Physiol., 21,201-206.
13. EGLEN, R.M., JAKEMAN, L. & ALVAREZ, R.A. (1994). The 5hydroxytryptaminey receptor. Expert Opin. Invest. Drugs, 3, 175-177.
14. EGLEN, R.M., JASPER, J.R., CHANG, D.J. & MARTIN, G.R. (1997). The 5-HT7 receptor: orphan found. Trends in Phannacol. Sei., 18, 10-107.
15. EHLERT, F.J. (1988). Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol. Phannacol., 33, 187-194.
16. ERLANDER, M.G., LOVENBERG, T.W., BARON, B.M., DELECEA, L., DANIELSON, P.E., RACKE, M., SLONE, A.L., SIEGEL, B.W., FOYE, P.E., CANNON, K., BRUNS, J.E. & SUTCLIFFE, J.G. (1993). Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. Proc. Nail. Acad. Sei. USA.. 90, 3452-3457.
17. FENIUK, W., HUMPHREY, P.P.A. & WATTS, A.D. (1984). 5hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Ear. J. Phannacol., 96, 71-78.
18. FURCHGOTT, R.F. (1972). The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Handbook of experimental pharmacology, catecholamines, Vol 33. (eds.) Blaschko, H. & Muscholl E. pp. 285-335. New York: SpringerVerlag.
19. GUSTAFSON, E.L., DURKIN, M.M., BARD, J.A., ZGOMBICK, J. & BRANCHEK, T.A. (1996). A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-ht7 receptor in rat brain. Br. J. Phannacol., 11, 657-666.
20. HEIDMANN, D.E.A., METCALF, M.A., KOHEN, R.& HAMBLIN, M.W. (1997). Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron -exon organisation. J. Neurochem..6S, 13-1381.
21. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-204.
22. JAVID, F.A. & NAYLOR, R.J. (1997). Characterisation of the 5-HT receptors mediating the contractile effect of 5-HT in the terminal region of the rat small intestine. Br. J. Plmrniacol., 11, 31 IP.
23. KALKMAN, H.O., ENGEL, G. & HOYER, D. (1986). Inhibition of 5carboxamidotryptamine-induced relaxation of guinea-pig ileum correlates with [l25l]LSD binding. Enr. J. Pharmacol.. 12, 139145.
24. KENAKIN, T. (1984). The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev., 36, 16-222.
25. KITAZAWA, T., KUBO, O., SATOH, M. & TANEIKE, T. (1998). Involvement of 5-hydroxytryptamine7 receptors in inhibition of porcine myometrial contractility by 5-hydroxytryptamine. Br. J. Pharmacol., 12, 173-182.
26. LANZAFAME, A., CHRISTOPOULOS, A. & MITCHELSON, F. (1996). Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors. Eur. J. Pharmacol., 31, 27-32.
27. LOVENBERG, T.W., BARON, B., DE LECEA, L., MILLER, J.D., PROSSER, R.A., REA, M.A., FOYE, P.E., RACKE, M., SLONE, A.L., SIEGEL, B.W., DANIELSON, P.E., SUTCLIFFE, J.G. &
28. ERLANDER, M.G. (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron, 11, 449-458.
29. LUCAS, J.J. & HEN, R. (1995). New players in the 5-HT receptor field: genes and knockouts. Trends in Pharmacol. Sei., 16, 246-252.
30. MARTIN, G.R. & WILSON, R.J. (1995). Operational characteristics of a 5-HT receptor mediating direct vascular relaxation: identity with the 5-HT7 receptor? Br. J. Pharmacol., 11, 383P.
31. McLEAN, P. & COUPAR, I.M. (1996). Characterisation of a postjunctional 5-ht7-like and a prejunctional 5-HT3 receptor mediating contraction of rat isolated jejunum. Eur. J. Pharmacol. .312, 215-225.
32. MONSMA, F.J., SHEN, Y., WARD, R.P., HAMBLIN, M.W. & SIBLEY, D.R. (1993). Cloning and expression of a novel serotonin receptor with high affinity for tricyclin psychotropic drugs. Mol. Pharmacol.. 43, 320-327.
33. NAMBA, T., SUGIMOTO, Y., NEGISHI, M., IRIE, A., USHIKUBI, F., KAZIZUKA, A., ITO, I., ICHIKAWA, A. & NARUMIYA, S. (1993). Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature, 36, 166-170.
34. PAZOS, A., HOYER, D. & PALACIOS, J.M. (1985). Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. Eur. J. Pharmacol., 10,531-538.
35. PINKUS, L.M., SARBIN, N.S., GORDON, J.C. & MUNSON JR, H.R. (1990). Antagonism of [3H]zacopride binding to 5-HT3 recognition sites by its (R) and (S) enantiomers. Eur. J. Pharmacol., 17, 231-235.
36. PLASSAT, J.L., AMLAIKY, N. & HEN, R. (1993). Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. A fol. Pharmacol., 44, 229-236.
37. RINNE, U.K. (1983). New ergot derivatives in the treatment of Parkinson's disease. In: Lisuride and other dopamine agonists. (eds.). Caine, D.B. et al., pp. 431-442. New York: Raven Press.
38. ROTH, B.L., CRAIGO, S.C., CHOUDHARY, M.S., ULUER, A., MONSMA, F.J., SHEN, Y., MELTZER, H.Y. & SIBLEY, D.R. (1994). Binding of typical and atypical antipsychotic agents to 5hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther., 26, 1403-1410.
39. RUAT, M., TRAIFFORT, E., LEURS, R., TARDIVEL-LACOMBE, J., DIAZ, J., ARRANG, J.-M. & SCHWARTZ, J.-C. (1993). Molecular cloning, characterization, and localization of a high affinity serotonin receptor (5-HT7) activating cyclic AMP formation. Proc. Natl. Acad. Sei. USA, 90, 8547-8551.
40. SHEN, Y., MONSMA Jr, F.J., METCALF, M.A., JOSE, P.A., HAMBLIN, M.W. & SIBLEY, D.R. (1993). Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem.,268, 18-18204.
41. SHENKER, A., MAAYANI, S., WEINSTEIN, H. & GREEN, J.P. (1987). Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea-pig hippocampal membranes. Mol. Pharmacol., 31, 357-367.
42. SLEIGHT, A.J., BOESS, F.G., BOURSON, A., SIBLEY, D.R. & MONSMA JR, F.J. (I995b). 5-HT6 and 5-HT7 serotonin receptors: Molecular biology and pharmacology. Neurotransmissions, 11, 1-5.
43. SLEIGHT, A.J., CAROLO, C., PETIT, N., ZWINGELSTEIN, C. & BOURSON, A. (1995a). Identification of 5-Hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity of chronic antidepressant treatment. Mol. Pharmacol., 47, 99-103.
44. SUMNER, M.J., FENIUK, W. & HUMPHREY, P.P.A. (1989). Further characterisation of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava. Br. J. Pharmacol., 97, 292-300.
45. SUNAHARA, R.K., DESSAUER, C.W. & OILMAN, A.G. (1996). Complexity and diversity of mammalian adenylyl cyclases. Ann. Rev. Pharmacol. Toxicol., 36, 461 -480.
46. TO, Z.P., BONHAUS, D.W., EGLEN, R.M. & JAKEMAN, L.B. (1995). Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain. Br. J. Pharmacol., 11, 107-116.
47. TSOU, A.P., KOSAKA, A., BACH, C., ZUPPAN, P., YEE, C., TOM, L., ALVAREZ, R., RAMSEY, S., BONHAUS, D.W., STEFANICH, E., JAKEMAN, L., EGLEN, R.M. & CHAN, H.W. (1994). Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase. J. Neurochem., 63, 456-464.
48. VANETTI, M., VOGT, G. & HOLLT, V. (1993). The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitisation. FEES Lett., 33, 260-266.
49. 2+ and Gs-coupled receptors in vivo. J. Biol. Chem., 26, 25400-25405.